T1 Mapping MOLLI 5(3)3 Acquisition Scheme Yields High Accuracy in 1.5 T Cardiac Magnetic Resonance

被引:2
|
作者
Krumm, Patrick [1 ]
Martirosian, Petros [2 ]
Brendel, Alexander [1 ]
Kuebler, Jens M. [1 ]
Brendel, Jan M. [1 ]
Gassenmaier, Sebastian [1 ]
Estler, Arne [1 ]
Gawaz, Meinrad [3 ]
Nikolaou, Konstantin [1 ]
Greulich, Simon [3 ]
机构
[1] Univ Tubingen, Dept Radiol Diagnost & Intervent Radiol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Radiol, Sect Expt Radiol, D-72076 Tubingen, Germany
[3] Univ Tubingen, Dept Internal Med Cardiol & Angiol 3, D-72076 Tubingen, Germany
关键词
T1; mapping; cardiac magnetic resonance imaging; MOLLI; accuracy;
D O I
10.3390/diagnostics12112729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To systematically compare two modified Look-Locker inversion recovery (MOLLI) T1 mapping sequences and their impact on (1) myocardial T1 values native, (2) post-contrast and (3) extracellular volume (ECV). Methods: 200 patients were prospectively included for 1.5 T CMR for work-up of ischemic or non-ischemic cardiomyopathies. To determine native and post-contrast T1 for ECV calculation, two different T1 mapping MOLLI acquisition schemes, 5(3)3 (designed for native scans with long T1) and 4(1)3(1)2 (designed for post-contrast scans with short T1), were acquired in identical mid-ventricular short-axis slices. Both schemes were acquired in native and post-contrast scans. Results: Datasets from 163 patients were evaluated (age 55 +/- 17 years; 38% female). Myocardial T1 native for 5(3)3 was 1017 +/- 42 ms vs. 956 +/- 40 ms for 4(1)3(1)2, with mean intraindividual difference -61 ms (p < 0.0001). Post-contrast myocardial T1 in patients was similar for both acquisition schemes, with 494 +/- 48 ms for 5(3)3 and 490 +/- 45 ms for 4(1)3(1)2 and mean intraindividual difference -4 ms. Myocardial ECV for 5(3)3 was 27.6 +/- 4% vs. 27 +/- 4% for 4(1)3(1)2, with mean difference -0.6 percentage points (p < 0.0001). Conclusions: The T1 MOLLI 5(3)3 acquisition scheme provides a reliable estimation of myocardial T1 for the clinically relevant range of long and short T1 values native and post-contrast. In contrast, the T1 MOLLI 4(1)3(1)2 acquisition scheme may only be used for post-contrast scans according to its designed purpose.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis
    Duca, Franz
    Kammerlander, Andreas A.
    Panzenboeck, Adelheid
    Binder, Christina
    Aschauer, Stefan
    Loewe, Christian
    Agis, Hermine
    Kain, Renate
    Hengstenberg, Christian
    Bonderman, Diana
    Mascherbauer, Julia
    JACC-CARDIOVASCULAR IMAGING, 2018, 11 (12) : 1924 - 1926
  • [2] Cardiac magnetic resonance T1 mapping in cardiac amyloidosis
    Duca, F.
    Zotter-Tufaro, C.
    Kammerlander, A.
    Panzenboeck, A.
    Binder, C.
    Aschauer, S.
    Koschutnik, M.
    Loewe, C.
    Schoenbauer, R.
    Agis, Hermine
    Hengstenberg, C.
    Bonderman, D.
    Mascherbauer, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 17 - 19
  • [3] Cardiac magnetic resonance T1 mapping. Part 1: Aspects of acquisition and evaluation
    Reiter, Gert
    Reiter, Clemens
    Kraeuter, Corina
    Fuchsjaeger, Michael
    Reiter, Ursula
    EUROPEAN JOURNAL OF RADIOLOGY, 2018, 109 : 223 - 234
  • [4] The effect of changes to MOLLI scheme on T1 mapping and extra cellular volume calculation in healthy volunteers with 3 tesla cardiovascular magnetic resonance imaging
    McDiarmid, Adam K.
    Broadbent, David A.
    Higgins, David M.
    Swoboda, Peter P.
    Kidambi, Ananth
    Ripley, David P.
    Erhayiem, Bara
    Musa, Tarique A.
    Dobson, Laura E.
    Greenwood, John P.
    Plein, Sven
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2015, 5 (04) : 503 - 510
  • [5] Validation of cardiac magnetic resonance T1 mapping in cardiac amyloidosis
    Duca, F.
    Zotter-Tufaro, C.
    Kammerlander, A. A.
    Panzenboeck, A.
    Aschauer, S.
    Boerries, B.
    Agis, H.
    Kain, R.
    Bonderman, D.
    Mascherbauer, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 846 - 846
  • [6] Validation of cardiac magnetic resonance T1 mapping in cardiac amyloidosis
    Duca, F.
    Zotter-Tufaro, C.
    Kammerlander, A.
    Panzenboeck, A.
    Aschauer, S.
    Boerries, B.
    Agis, H.
    Kain, R.
    Bonderman, D.
    Mascherbauer, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S8 - S9
  • [7] Improved cardiac T1 mapping accuracy and precision with a new hybrid MOLLI and SASHA technique: MOSHA
    Sohani, Majid
    van der Geest, Rob J. J.
    Maier, Andreas
    Powell, Andrew J. J.
    Moghari, Mehdi H. H.
    MAGNETIC RESONANCE IMAGING, 2022, 89 : 33 - 41
  • [8] Myocardial T1 mapping at 3 tesla in vitro and in vivo performance of two new MOLLI variants 3 3 MOLLI and centric-paired MOLLI
    Cameron, D.
    Higgins, D.
    Jagpal, B.
    Stehning, C.
    Frenneaux, M. P.
    Redpath, T. W.
    Dawson, D.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1021 - 1022
  • [9] Phantom validation of 17 and 11 heartbeat MOLLI T1 mapping sequence at 3T
    Songtao Liu
    Justin Huang
    Martin Ugander
    Christopher Sibley
    Abiola Oki
    Jing Han
    Andreas Greiser
    Daniel R Messroghli
    Peter Kellman
    Andrew E Arai
    David A Bluemke
    Journal of Cardiovascular Magnetic Resonance, 13 (Suppl 1)
  • [10] T1 values in discrimination between health and disease using different T1 sequences: comparison between 3'3'5-MOLLI, 3'5-MOLLI, shMOLLI and SASHA
    Islam Z Mahmoud
    Ciara Cummins
    Zakir Hussain
    Toby Rogers
    Darius Dabir
    Tobias Voigt
    David M Higgins
    Eike Nagel
    Tobias Schaeffter
    Valentina Puntmann
    Journal of Cardiovascular Magnetic Resonance, 16 (Suppl 1)